Lunt, Michael
Lunt, Michael was paid $2.34M by Medicaid between Jan 2018 and Nov 2024, across 157 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 21% of everything it billed.
PEORIA, IL 61637
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,204 | $205K | |
| 2019 | 39,376 | $241K | |
| 2020 | 32,565 | $228K | |
| 2021 | 47,969 | $593K | |
| 2022 | 53,324 | $560K | |
| 2023 | 41,753 | $338K | |
| 2024incomplete | 33,156 | $173K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 21% | 8,679 | 7,125 | $492K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 6.1% | 580 | 548 | $143K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5.9% | 3,056 | 2,853 | $137K |
| 80053 | Comprehensive metabolic panel | 5.8% | 26,835 | 21,547 | $136K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.4% | 4,691 | 4,521 | $103K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.4% | 4,690 | 4,520 | $103K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.2% | 34,782 | 25,337 | $99K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.6% | 1,709 | 1,608 | $83K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.4% | 7,039 | 6,605 | $56K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.2% | 2,157 | 1,834 | $51K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 1,180 | 1,031 | $44K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.8% | 8,567 | 7,863 | $43K |
145 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.6% | 546 | $38K |
| 87480 | 1.6% | 2,928 | $37K | |
| 87510 | 1.6% | 2,918 | $37K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.6% | 8,749 | $37K |
| 82803 | 1.3% | 2,798 | $30K | |
| 83735 | 1.3% | 8,358 | $29K | |
| 88342 | 1.2% | 1,750 | $27K | |
| 87660 | 1.1% | 3,038 | $25K | |
| 87040 | 1.1% | 2,562 | $25K | |
| 83605 | <1% | 4,268 | $23K | |
| 87641 | <1% | 963 | $21K | |
| 82962 | <1% | 11,447 | $21K | |
| 82330 | <1% | 2,189 | $19K | |
| 87081 | <1% | 6,560 | $19K | |
| 84484 | <1% | 3,517 | $18K | |
| 80061 | Lipid panel | <1% | 4,750 | $16K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,079 | $15K |
| 87186 | <1% | 2,709 | $15K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,987 | $14K |
| 85730 | <1% | 3,090 | $13K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 993 | $13K |
| 86780 | <1% | 1,468 | $12K | |
| 85610 | <1% | 5,628 | $12K | |
| 83880 | <1% | 1,107 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,485 | $11K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 182 | $11K |
| 83690 | <1% | 3,024 | $10K | |
| 86850 | <1% | 3,354 | $10K | |
| 88307 | <1% | 161 | $9K | |
| 81025 | <1% | 4,341 | $9K | |
| 80069 | <1% | 2,128 | $9K | |
| 81001 | <1% | 6,105 | $9K | |
| 84100 | <1% | 3,920 | $9K | |
| 86901 | <1% | 3,618 | $8K | |
| 84439 | <1% | 1,924 | $8K | |
| 82607 | <1% | 1,412 | $8K | |
| 86803 | <1% | 955 | $8K | |
| 86140 | <1% | 3,032 | $7K | |
| 80202 | <1% | 882 | $6K | |
| 86900 | <1% | 3,591 | $6K | |
| 82728 | <1% | 1,575 | $6K | |
| 84466 | <1% | 1,349 | $6K | |
| 85384 | <1% | 1,735 | $6K | |
| 87088 | <1% | 1,019 | $5K | |
| 87581 | <1% | 243 | $5K | |
| 87340 | <1% | 733 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 619 | $5K |
| 87147 | <1% | 2,789 | $5K | |
| 82570 | <1% | 1,925 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 239 | $5K |
| 84702 | <1% | 1,043 | $5K | |
| 85027 | <1% | 1,569 | $5K | |
| 85379 | <1% | 1,228 | $5K | |
| 87070 | <1% | 1,455 | $5K | |
| 82784 | <1% | 628 | $4K | |
| 83970 | <1% | 292 | $4K | |
| 82805 | <1% | 180 | $4K | |
| 87486 | <1% | 184 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 170 | $4K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 185 | $4K |
| 82550 | <1% | 1,278 | $4K | |
| 81003 | <1% | 3,668 | $4K | |
| 82746 | <1% | 682 | $4K | |
| 83540 | <1% | 1,205 | $4K | |
| 88341 | <1% | 78 | $4K | |
| 83615 | <1% | 1,182 | $3K | |
| 86003 | <1% | 135 | $3K | |
| 85014 | <1% | 2,335 | $3K | |
| 86038 | <1% | 381 | $3K | |
| 87493 | <1% | 116 | $3K | |
| 85652 | <1% | 1,778 | $2K | |
| 80047 | <1% | 447 | $2K | |
| 83516 | <1% | 356 | $2K | |
| 87077 | <1% | 475 | $2K | |
| 82043 | <1% | 1,029 | $2K | |
| 84703 | <1% | 551 | $2K | |
| 86920 | <1% | 414 | $2K | |
| 80074 | <1% | 97 | $2K | |
| 84550 | <1% | 851 | $2K | |
| 87205 | <1% | 940 | $2K | |
| 86480 | <1% | 72 | $2K | |
| 87536 | <1% | 40 | $2K | |
| 82565 | <1% | 746 | $2K | |
| 84478 | <1% | 720 | $2K | |
| 86762 | <1% | 370 | $2K | |
| 87075 | <1% | 222 | $2K | |
| 80076 | <1% | 379 | $1K | |
| 84146 | <1% | 201 | $1K | |
| 85018 | <1% | 1,197 | $1K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 133 | $1K |
| 84295 | <1% | 589 | $1K | |
| 84481 | <1% | 233 | $1K | |
| 84132 | <1% | 546 | $1K | |
| 84156 | <1% | 900 | $1K | |
| 82248 | <1% | 445 | $924.14 | |
| 85045 | <1% | 749 | $917.07 | |
| 88304 | <1% | 50 | $868.62 | |
| 82247 | <1% | 322 | $820.46 | |
| 82785 | <1% | 162 | $781.93 | |
| 82947 | <1% | 397 | $707.01 | |
| 87807 | <1% | 123 | $660.00 | |
| 82140 | <1% | 145 | $622.88 | |
| 80306 | <1% | 99 | $594.50 | |
| 87505 | <1% | 12 | $581.58 | |
| 83655 | <1% | 103 | $557.53 | |
| 86360 | <1% | 56 | $508.26 | |
| 80164 | <1% | 104 | $498.47 | |
| 86706 | <1% | 66 | $433.36 | |
| 86359 | <1% | 57 | $412.46 | |
| 85347 | <1% | 145 | $390.74 | |
| 80177 | <1% | 77 | $364.07 | |
| 87522 | Neg quan hep c or qual rna | <1% | 12 | $363.35 |
| 86880 | <1% | 105 | $353.80 | |
| 82951 | <1% | 48 | $314.26 | |
| 87184 | <1% | 66 | $277.77 | |
| 85049 | <1% | 206 | $250.80 | |
| 84480 | <1% | 54 | $246.20 | |
| 86308 | <1% | 100 | $234.48 | |
| 82670 | <1% | 27 | $208.83 | |
| 86431 | <1% | 48 | $173.06 | |
| 82274 | <1% | 32 | $164.09 | |
| 86738 | <1% | 19 | $127.50 | |
| 82272 | <1% | 101 | $117.36 | |
| 87045 | <1% | 15 | $114.35 | |
| 87210 | <1% | 36 | $113.98 | |
| 86376 | <1% | 24 | $111.09 | |
| 86645 | <1% | 12 | $109.44 | |
| 83020 | <1% | 25 | $103.44 | |
| 82627 | <1% | 17 | $100.79 | |
| 82533 | <1% | 14 | $99.93 | |
| 86695 | <1% | 12 | $91.80 | |
| 88312 | <1% | 14 | $82.60 | |
| 86200 | <1% | 13 | $70.46 | |
| 84300 | <1% | 31 | $68.30 | |
| 82950 | <1% | 28 | $65.24 | |
| 83010 | <1% | 14 | $62.02 | |
| 87102 | <1% | 17 | $58.90 | |
| 88141 | <1% | 16 | $55.55 | |
| 82009 | <1% | 32 | $43.52 | |
| 81015 | <1% | 40 | $36.68 | |
| 83050 | <1% | 13 | $31.98 | |
| 87046 | <1% | 16 | $28.11 | |
| 89050 | <1% | 14 | $26.25 | |
| 82945 | <1% | 14 | $18.48 | |
| 84157 | <1% | 13 | $15.60 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.